Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644

Circulation

Volumn 93, Issue 9, 1996, Pages 1747-1754

  Leistad, Elisabeth ^a   Aksnes, Gunnar ^a   Verburg, Esther ^a   Christensen, Geir ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

atrium; calcium channels; contractility; drugs; fibrillation

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ADENOSINE TRIPHOSPHATE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; LACTIC ACID; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART ATRIUM CONTRACTILITY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART DEPOLARIZATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SARCOLEMMA;

EID: 0029914565     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.9.1747     Document Type: Article

References (57)

1. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology. 1978;28:973-977.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med. 1982;306:1018-1022.
3. Pollick C, Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography: implications for the development of thrombus. Circulation. 1991;84:223-231.
4. Fatkin D, Feneley MP, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 1994;23:961-969.
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22:983-988.
6. Shapiro EP, Effron MB, Lima S, Ouyang P, Siu CO, Bushi D. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol. 1988;62:1202-1207.
7. Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol. 1989;13:617-623.
8. Van Gelder IC, Crijns HJGM, Blanksma PK, Landsman MLJ, Posma JL, Van Den Berg MP, Meijler FL, Lie KI. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiacvalve disease. Circulation. 1994;72:560-566.
9. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE, Klein AL. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 1993;22:1359-1366.
10. Black IW, Fatkin D, Sagar KB, Khanderia BK, Leung DY, Galloway JM, Feneley MP, Walsh WF, Grimm RA, Stollberger C, Verhorst PMJ, Klein AL. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. Circulation. 1994;89:2509-2513.
11. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for 'atrial stunning' as a mechanism of thromboembolic complications. J Am Coll Cardiol. 1994;23:307-316.
12. Leung DYC, Black IW, Cranney GB, Hopkins AP, Walsh WF. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol. 1994;24:755-762.
13. Fatkin D, Herbert E, Feneley MP. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol. 1994;73:672-676.
14. Graettinger JS, Carleton RA, Muenster JJ. Circulatory consequences of changes in cardiac rhythm produced in patients by transthoracic direct-current shock. J Clin Invest. 1964;43:2290-2302.
15. Logan WFWE, Rowlands DJ, Howitt G, Holmes AM. Left atrial activity following cardioversion. Lancet. 1965;2:471-473.
16. Dethy M, Chassat C, Roy D, Mercier L-A. Doppler echocardiographic predictors of recurrence of atrial fibrillation after cardioversion. Am J Cardiol. 1988;62:723-726.
17. Macierho-Coelho E, Alves MG, Granate J, Coelho E. Atrial activity following conversion of experimental atrial fibrillation by direct current shock. Acta Cardiol. 1968;23:439-453.
18. Leistad E, Christensen G, Ilbekk A. Atrial contractile performance after cessation of atrial fibrillation. Am J Physiol. 1993;264: H104-H109.
19. Lee H-C, Clusin WT. Cytosolic calcium staircase in cultured myocardial cells. Circ Res. 1987;61:934-939.
20. 2+ current in frog ventricular myocytes by the holding potential, c-AMP and frequency. Pflugers Arch. 1989;415:1-11.
21. Kitakaze M, Weisman HF, Marban E. Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation. 1988;77:685-695.
22. Koretsune Y, Marban E. Cell calcium in the pathophysiology of ventricular fibrillation and in the pathogenesis of postarrhythmic contractile dysfunction. Circulation. 1989;80:369-379.
23. Pagani M, Vatner SF, Baig H, Braunwald E. Initial myocardial adjustments to brief periods of ischemia and reperfusion in the conscious dog. Circ Res. 1978;43:83-92.
24. Steiner C, Kovalik TW. A simple technique for production of chronic complete heart block in dogs. J Appl Physiol. 1968;25: 631-632.
25. Bayer R, Kaufmann R, Mannhold D. Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium, I: pattern of inotropic effects of the racemic compounds. Naunyn Schmiedebergs Arch Pharmacol. 1975;290:49-68.
26. Ehara T, Daufman R. The voltage- and time-dependent ettects of (-)-verapamil on the slow inward current in isolated ventricular myocardium. J Pharmacol Exp Ther. 1978;207:49-55.
27. Leistad E, Christensen G, Ilebekk A. Right and left atrial diameters during incremental atrial pacing in pigs. Am J Physiol. 1991;260: H973-H978.
28. Recordati G, Lombardi F, Malliani A, Brown AM. Instantaneous dimensional changes of the right atrium in the cat. J Appl Physiol. 1974;36:686-692.
29. 2+ infusion, and aortic constriction in pigs. Circ Res. 1991;68:638-644.
30. Lundin A, Rickardsson A, Thore A. Continuous monitoring of ATP-converting reactions by purified firefly luciferase. Anal Biochem. 1976;75:611-620.
31. Lowry OH, Passonneau JV. A Flexible System of Enzymatic Analysis. New York, NY: Academic Press; 1972:146-201.
32. Conover WJ. Practical Nonparametric Statistics. 2nd ed. New York, NY: John Wiley & Sons; 1980:299-300.
33. Thandroyen FT, Morris AC, Hagler HK, Ziman B, Pai L, Willerson JT, Buja LM. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ Res. 1991;69:810-819.
34. Wier WG, Yue DT. Intra-cellular calcium transients underlying the short-term force-interval relationship in ferret ventricular myocardium. J Physiol (Lond). 1986;376:507-530.
35. Boyett MR, Frampton JE, Harrison SM, Kirby MS, Levi AJ, McCall E, Milner DR, Orchard CH. The role of intracellular calcium, sodium and pH in rate-dependent changes of cardiac contractile force. In: Noble MIM, Seed WA, eds. The Interval-Force Relationship of the Heart: Bowditch Revisited. New York, NY: Cambridge University Press; 1992:111-172.
36. 2+ transients underlie stunning? Circ Res. 1990;66:1268-1276.
37. 2+ responsiveness of the contractile proteins in intact stunned myocardium. Circulation. 1994;90(suppl I):I-646. Abstract.
38. Atar D, Gao WD, Backx PH, Murphy AM, Marban E. Immunoblot analysis of stunned myocardium reveals structural alterations of the myofilaments predicted by modeling of cross-bridged kinetics. Circulation. 1994;90(suppl I):I-646. Abstract.
39. 2+ sensitivity. Circulation. 1994;90(suppl I):I-646. Abstract.
40. Williams JF Jr, Sonnenblick EH, Braunwald E. Determinants of atrial contractile force in the intact heart. Am J Physiol. 1965;209: 1061-1068.
41. Payne RM, Stone HL, Engelken EJ. Atrial function during volume loading. J Appl Physiol. 1971;31:326-331.
42. Goldman S, Olajos M, Morkin E. Comparison of left atrial and left ventricular performance in conscious dogs. Cardiovasc Res. 1984;18: 604-612.
43. Matsuzaki M, Tamitani M, Toma Y, Ogawa H, Katayama K, Matsuda Y, Kusukawa R. Mechanism of augmented left atrial pump function in myocardial infarction and essential hypertension evaluated by left atrial pressure-dimension relation. Am J Cardiol. 1991;67:1121-1126.
44. Bechem M, Hoffman H. The molecular mode of action of the Ca agonist (-) Bay K 8644 on the cardiac Ca channel. Pflugers Arch. 1993;424:343-353.
45. Hess P, Lansman JB, Tsien RW. Different modes of Ca channel gating behaviour favoured by dihydropyidine Ca agonists and antagonists. Nature. 1984;311:538-544.
46. 2+ channels. Nature. 1983;303:535-537.
47. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial function and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest. 1975;56:978-985.
48. Smetnev AS, Bunin I, Nargizian AB, Petrovskii PF, Vakhliaev VD. Characteristics in the metabolism in the myocardium of patients with auricular fibrillation. Kardiologiia. 1983;23:70-73.
49. Lau C-P, Leung W-H, Wong C-K, Cheng C-H. Haemodynamics of induced atrial fibrillation: a comparative assessment with sinus rhythm atrial and ventricular pacing. Eur Heart J. 1990;11:219-224.
50. White CW, Kerber RE, Weiss HR, Marcus ML. The effects of atrial fibrillation on atrial pressure-volume and flow relationships. Circ Res. 1982;51:205-215.
51. White CW, Holida MD, Marcus ML. Effects of acute atrial fibrillation on the vasodilator reserve of the canine atrium. Cardiovasc Res. 1986;20:683-689.
52. Borgers M, Ausma J, Wijffels M, Allessie M. Atrial fibrillation in the goat: a model for chronic hibernating myocardium. Circulation. 1994;90(suppl I):I-467. Abstract.
53. Borgers M, De Nollin S, Thonè F, Wouters L, VanVaeck L, Flameng W. Distribution of calcium in a subset of chronic hibernating myocardium in man. Histochem J. 1993;25:312-318.
54. Davies MJ, Pomerance A. Pathology of atrial fibrillation in man. Br Heart J. 1972;34:520-525.
55. Mary-Rabine L, Albert A, Pham TD, Hordof A, Fenoglio JJ, Malm JR, Rosen MR. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ Res. 1983;52: 188-199.
56. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91:1588-1595.
57. Bierkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation. Am J Cardiol. 1969;23:208-216.